Increased extrapyramidal symptoms with addition of lithium to neuroleptics.

Extrapyramidal symptoms with addition of lithium to neuroleptics. J Nerv Ment Dis (1989) 0.81

Incidence of adverse reactions to commonly prescribed psychopharmacological agents during early phase of therapy. Indian J Psychiatry (1995) 0.78

Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus. Nature (1980) 4.43

Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses. J Biol Chem (1982) 2.59

Relationship of lithium chloride dose to treatment response in acute mania. Arch Gen Psychiatry (1976) 1.81

Effect of alcohol and various diseases on leukocyte mobilization, phagocytosis and intracellular bacterial killing. N Engl J Med (1970) 1.75

Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry (1987) 1.65

The pharmacologic treatment of neuroleptic-induced akathisia. J Clin Psychopharmacol (1990) 1.39

Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry (1986) 1.17

Effects of lithium carbonate on associative productivity and idiosyncrasy in bipolar outpatients. Am J Psychiatry (1986) 1.06

Pain perception in self-injurious patients with borderline personality disorder. Biol Psychiatry (1992) 1.03

Circadian rest-activity rhythms in demented and nondemented older community residents and their caregivers. J Am Geriatr Soc (1997) 0.97

Efficacy of lithium as acute treatment of manic-depressive illness. Lancet (1971) 0.96

Papilledema following therapeutic dosages of lithium carbonate. J Nerv Ment Dis (1978) 0.95

Dexamethasone suppression in dementia, depression, and normal aging. Am J Psychiatry (1986) 0.94

Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med (1985) 0.94

Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry (1985) 0.91

Direct comparison of two widely used activity recorders. Sleep (1998) 0.90

Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry (1984) 0.89

Specificity of mixed affective states: clinical comparison of dysphoric mania and agitated depression. J Affect Disord (1993) 0.85

Anal duct carcinoma: report of case and a survey of the experience of the American Osteopathic College of Proctology. J Am Osteopath Assoc (2001) 0.84

Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology (1994) 0.83

Adrenocortical activation in alcoholics during chronic drinking. Ann N Y Acad Sci (1973) 0.83

Subjective awareness of abnormal involuntary movements in chronic schizophrenic patients. Am J Psychiatry (1990) 0.83

Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res (1988) 0.82

Insulin tolerance test: human growth hormone response and insulin resistance in primary unipolar depressed, bipolar depressed and control subjects. Psychol Med (1982) 0.81

Depressive behavior and hyperactive adrenocortical function. Am J Psychiatry (1985) 0.81

Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance. Psychiatry Res (1989) 0.81

Stable isotopes of lithium: in vivo differential distribution between plasma and cerebrospinal fluid. Biol Psychiatry (1982) 0.80

Pain perception in self-injurious borderline patients: naloxone effects. Biol Psychiatry (1994) 0.80

Aberrant parenting and delayed offspring development in rats exposed to lithium. Biol Psychiatry (1986) 0.80

Psychomotor performance and monoamine function in bipolar and unipolar affective disorders. Biol Psychiatry (1999) 0.80

Subsensitivity of adenylyl cyclase-coupled receptors on mononuclear leukocytes from drug-free inpatients with a major depressive episode. Biol Psychiatry (1997) 0.79

Neuropsychologic effects of lithium discontinuation. J Clin Psychopharmacol (1993) 0.79

Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Drug Saf (1998) 0.79

Temporal changes in growth hormone, cortisol, and glucose: relation to light onset and behavior. Am J Physiol (1975) 0.79

Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand (1992) 0.79

Psychopathology and plasma cortisol responses to dexamethasone in prepubertal psychiatric inpatients. Biol Psychiatry (1989) 0.78

Lithium ratio and maintenance treatment response. J Affect Disord (1982) 0.78

Threshold doses of 2-deoxy-D-glucose for hyperglycemia and feeding in rats and monkeys. Am J Physiol (1972) 0.78

Effect of alcohol on auditory and visual time perception. Q J Stud Alcohol (1970) 0.77

Dexamethasone suppression in major depression. Biol Psychiatry (1984) 0.77

Stress, depression, and mania: relationship between perceived role of stressful events and clinical and biochemical characteristics. Acta Psychiatr Scand (1990) 0.77

Classically conditioned changes in plasma cortisol levels induced by dexamethasone in healthy men. FASEB J (1997) 0.77

Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function. Biol Psychiatry (1994) 0.77

Relationship of platelet MAO activity to characteristics of major depressive illness. Psychiatry Res (1986) 0.76

Hypercortisolemia decreases dexamethasone half-life in rabbit. J Psychiatr Res (2002) 0.76

Adrenocortical function and suicidal behavior in depressive disorders. Psychiatry Res (1986) 0.76

Nocturnal interactions between community elders and caregivers, as measured by cross-correlation of their motor activity. J Geriatr Psychiatry Neurol (1997) 0.76

Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity. Am J Psychiatry (1987) 0.76

Relationship of 24-hour urinary free cortisol to 4-hour salivary morning and afternoon cortisol and cortisone as measured by a time-integrated oral diffusion sink. J Endocrinol Invest (1995) 0.76

Effect of 2-deoxy-D-glucose on insulin response to glucose in intact and adrenalectomized monkeys. Endocrinology (1973) 0.76

Adrenomedullary function in depressed patients. J Psychiatr Res (1995) 0.75

Effects of lithium carbonate on the memory and motor speed of bipolar outpatients. J Abnorm Psychol (1987) 0.75

New psychopharmacologic treatment strategies. Ann Intern Med (2001) 0.75

Thyroid function in patients maintained on lithium. Psychiatry Res (1988) 0.75

Increase in CSF protein in association with ECT. J Neurol Neurosurg Psychiatry (1978) 0.75

[Study of 100 manic depressive patients: I. Retrospective evaluation of their treatment with lithium; various aspects of the natural history of the disease]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1977) 0.75

Changes of 17-hydroxycorticosteroids and growth hormone during self-stimulation in monkeys. Physiol Behav (1974) 0.75

High-dose lithium therapy. Biol Psychiatry (1978) 0.75

Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder. Acta Psychiatr Scand (1987) 0.75

Changes of plasma glucose and insulin during defense reactions in monkeys. Am J Physiol (1973) 0.75

Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. Am J Psychiatry (1984) 0.75

The influence of blood chemistry on T4 and FT4I in major depression. J Affect Disord (1990) 0.75

Platelet MAO during the alcohol withdrawal syndrome. Am J Psychiatry (1981) 0.75

Reuptake of biogenic amines by brain slices: effect of hydrocortisone. Psychopharmacology (Berl) (1980) 0.75

Characteristics of the uptake of lithium isotopes into erythrocytes. Biol Psychiatry (1979) 0.75

The relationship of the dexamethasone suppression test to subtypes of depression and to symptomatic severity in the elderly. J Affect Disord (1986) 0.75

Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications. Biol Psychiatry (1984) 0.75

Lithium isotopes: differential effects on renal function and histology. Bipolar Disord (2001) 0.75

Insulin-induced hypoglycaemic response and release of growth hormone in depressed patients and healthy controls. Psychol Med (1988) 0.75

Rubidium uptake into red blood cells compared with that of lithium. Biol Psychiatry (1982) 0.75

Relationship between avoidance-induced arousal and plasma DBH, glucose and renin activity. Physiol Behav (1977) 0.75

Lithium toxicology: effect of isotopic composition on lethality and behavior. Pharmacol Biochem Behav (1982) 0.75

Lithium metabolism and intracellular electrolytes. Brain Res Bull (1991) 0.75

Unexpected neuroendocrine-transmitter relationships [proceedings]. Psychopharmacol Bull (1981) 0.75

Dexamethasone suppression test in geriatric depression. Biol Psychiatry (1984) 0.75

Psychopathologic and metabolic changes in a patient with myxedema psychosis treated with L-tri-iodothyronine. Am J Psychiatry (1967) 0.75

Plasma 17-hydroxycorticosteroids and growth hormone during defense reactions. Am J Physiol (1974) 0.75

DST update: the hypothalamic-pituitary-adrenocortical axis and affective illness. Biol Psychiatry (1987) 0.75

Interepisode consistency of dexamethasone suppression test results in affective disorders. Am J Psychiatry (1986) 0.75

Plasma glucose and insulin levels in monkeys anticipating feeding. Pavlov J Biol Sci (1983) 0.75

Path analysis of psychopharmacological data: catecholamine breakdown in man. Psychiatry Res (1986) 0.75

The familial history in sixteen males with bipolar manic-depressive illness. Proc Annu Meet Am Psychopathol Assoc (1975) 0.75

Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. Arch Gen Psychiatry (1988) 0.75

The relationship between endorphins and alcohol-induced subcortical activity. Am J Psychiatry (1980) 0.75

Symptomatic predictors of ECT response in medication-nonresponsive manic patients. J Clin Psychiatry (1992) 0.75

Biological component of the NIMH clinical research branch collaborative program on the psychobiology of depression: I. Background and theoretical considerations. Psychol Med (1980) 0.75

Alcoholism. Prog Neurol Psychiatry (1971) 0.75

Lithium maintenance: factors affecting outcome. Am J Psychiatry (1979) 0.75

Plasma cortisol and appetitively motivated arousal in monkeys. Behav Neurosci (1984) 0.75

[Use of lithium in a clinic for continuous treatment of manic depressive patients]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1978) 0.75

Changes in human ERG induced by intravenous alcohol. Ophthalmologica (1969) 0.75

[100 manic-depressive patients. III. Clinical cases]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1977) 0.75

Ultradian rhythms in cognitive functions and their relationship to visceral processes. Physiol Behav (1983) 0.75